LANXESS Aktiengesellschaft

SWX:LXS Stock Report

Market Cap: CHF2.2b

LANXESS Valuation

Is LXS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of LXS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: LXS (CHF56.2) is trading below our estimate of fair value (CHF96.71)

Significantly Below Fair Value: LXS is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for LXS?

Other financial metrics that can be useful for relative valuation.

LXS key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.7x
Enterprise Value/EBITDA11.5x
PEG Ration/a

Price to Sales Ratio vs Peers

How does LXS's PS Ratio compare to its peers?

The above table shows the PS ratio for LXS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.9x
CLN Clariant
1x3.8%CHF4.5b
VETN Vetropack Holding
0.7x2.7%CHF616.5m
EMSN EMS-CHEMIE HOLDING
7.8x4.5%CHF17.2b
SIGN SIG Group
2.2x4.5%CHF7.0b
LXS LANXESS
0.3x2.6%CHF2.3b

Price-To-Sales vs Peers: LXS is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (2.9x).


Price to Earnings Ratio vs Industry

How does LXS's PE Ratio compare vs other companies in the European Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a10.2%
n/an/an/a
No. of CompaniesPS048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a10.2%
n/an/an/a
No more companies

Price-To-Sales vs Industry: LXS is good value based on its Price-To-Sales Ratio (0.3x) compared to the European Chemicals industry average (1x).


Price to Sales Ratio vs Fair Ratio

What is LXS's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

LXS PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.3x
Fair PS Ratio0.7x

Price-To-Sales vs Fair Ratio: LXS is good value based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (0.7x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst LXS forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF56.20
CHF27.52
-51.0%
17.4%CHF41.06CHF20.53n/a19
Apr ’25CHF56.20
CHF27.32
-51.4%
18.6%CHF40.81CHF20.40n/a19
Mar ’25CHF56.20
CHF26.82
-52.3%
18.9%CHF39.29CHF19.64n/a18
Feb ’25CHF56.20
CHF26.89
-52.2%
18.9%CHF39.39CHF19.70n/a18
Jan ’25CHF56.20
CHF27.54
-51.0%
20.1%CHF39.77CHF19.88n/a18
Dec ’24CHF56.20
CHF30.74
-45.3%
31.6%CHF62.80CHF20.29n/a19
Nov ’24CHF56.20
CHF31.45
-44.0%
29.4%CHF61.40CHF22.67n/a19
Oct ’24CHF56.20
CHF35.63
-36.6%
29.1%CHF62.90CHF24.19n/a19
Sep ’24CHF56.20
CHF37.10
-34.0%
25.9%CHF62.07CHF26.74n/a20
Aug ’24CHF56.20
CHF39.19
-30.3%
27.8%CHF62.48CHF22.40n/a20
Jul ’24CHF56.20
CHF41.16
-26.8%
26.2%CHF63.50CHF22.76n/a21
Jun ’24CHF56.20
CHF48.45
-13.8%
18.9%CHF67.02CHF34.00n/a21
May ’24CHF56.20
CHF50.08
-10.9%
18.3%CHF68.01CHF34.50CHF56.2021
Apr ’24CHF56.20
CHF50.04
-11.0%
17.9%CHF68.20CHF34.60CHF56.2021
Mar ’24CHF56.20
CHF51.64
-8.1%
14.8%CHF68.15CHF39.50CHF56.2021
Feb ’24CHF56.20
CHF52.36
-6.8%
14.7%CHF69.15CHF40.09CHF56.2021
Jan ’24CHF56.20
CHF49.88
-11.2%
17.3%CHF68.16CHF37.04CHF56.2021
Dec ’23CHF56.20
CHF50.12
-10.8%
17.3%CHF70.86CHF36.91CHF56.2021
Nov ’23CHF56.20
CHF49.54
-11.9%
21.1%CHF70.56CHF30.87CHF56.2021
Oct ’23CHF56.20
CHF51.34
-8.6%
17.8%CHF69.61CHF33.84CHF56.2020
Sep ’23CHF56.20
CHF52.63
-6.3%
16.8%CHF70.31CHF37.11CHF56.2020
Aug ’23CHF56.20
CHF56.85
+1.2%
15.2%CHF71.37CHF39.65CHF56.2019
Jul ’23CHF56.20
CHF61.06
+8.6%
12.1%CHF72.01CHF40.01CHF56.2019
Jun ’23CHF56.20
CHF62.07
+10.5%
11.5%CHF71.85CHF46.19CHF56.2020
May ’23CHF56.20
CHF64.23
+14.3%
11.5%CHF76.32CHF44.78CHF56.2021

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.